Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

It’s IGN Fan Fest week where we’ll be rolling out news and exclusives leading up to our two-day livestream this Friday, February 23, and Saturday, February 24, across multiple platforms. Today, we ...

I had already watched "River" from Junta Yamaguchi, and I knew more or less what to expect by watching "Beyond the infinite two minutes". The actors play perfectly, and each character depicted in the ...